期刊文献+

难治性癫痫相关耐药蛋白在局灶性皮质发育不良脑组织中的表达 被引量:4

Expression of refractory epilepsy related drug resistance proteins in brain tissue of focal cortical dysplasia
原文传递
导出
摘要 目的 通过对P-糖蛋白、多药耐药相关蛋白和肺耐药相关蛋白在难治性癫痫相关局灶性皮质发育不良脑组织中表达部位的初步研究,以及对其在不同程度病变脑组织中表达量的比较,进一步阐明难治性癫疴的耐药机制,为癫痫患者的临床合理用药提供理论依据.方法 选取16例难治性癫痫患者手术切除脑组织标本作为患者组(局灶性皮质发育不良Ⅰ型和Ⅱ型患者各8例),5例无癫痫发作病史的胶质瘤患者手术切除脑组织标本的非病灶区域作为对照组.应用Envision二步法进行免疫组织化学标记,观察3种耐药蛋白在脑组织中的表达部位和表达强度;应用Western blot法进行SDS-聚丙烯酰胺凝胶电泳,对3种耐药蛋白在脑组织中的表达进行定量分析.结果 P-糖蛋白主要表达于毛细血管内皮细胞,多药耐药相关蛋白主要表达于脑组织内的神经元成分,肺耐药相关蛋白的表达则涌盖了毛细血管内皮细胞、气球细胞及病灶区域部分基质.3种耐药蛋白在局灶性皮质发育不良脑组织中的表达均显著高于对照组脑组织(P-糖蛋白:0.520±0.121,多药耐药蛋白:0.132±0.018,肺耐药相关蛋白:0.092 4-0.018,U=0.000,P〈0.01),其中P-糖蛋白和肺耐药相关蛋白在局灶性皮质发育不良Ⅱ型患者的病灶区域(3.809±0.842、0.655±0.303)表达高于病灶周围区域(2.636 4±0.622、0.290±0.096,U=6.000、4.500,P〈0.01).结论 P-糖蛋白、多药耐药相关蛋白和肺耐药相关蛋白在不同程度的局灶性皮质发育不良脑组织中具有不同的表达部位和表达量,提示其作用机制和作用强度有所差异. Objective To study the locations of P-glycoprotein(P-gp),multi-drug resistanceassociated protein (MRP) and lung resistance.related protein(LRP)in brain tissue of focal cortical dysplasia (FCD) and to compare the quantity of these proteins in different brain tissues in an effort to study the mechanism of refractory epilepsy and to provide theoretical basis for medical treatment in patients with epilepsy.Methods The brain tissues of 16 cases with refractory epilepsy were collected during surgery,including 8 cases of focal cortical dysplasia type Ⅰ(FCD Ⅰ)and 8 cases of focal cortical dysplasia type Ⅱ (FCD Ⅱ) Five cases of glioma without history of epilepsy were included as the control group.Envision method was used to observe the location and intensity of expression of these three proteins.Western-Blot was used to analyze these proteins quantitatively.Results In brain tissue,the locations of P-glycoprotein,multi-drug resistance-associated protein and lung resistance-related protein were difierent.P-gp located mainly in capillary endothelial cells;MRP in neurons components;the location of LRP included capillary endothelial cells,balloon cells and the matrix of lesions.The expressions of three proteins in brain tissue of FCD were significantly higher than in control group(P-gp:0.520 ±0.121,MRP:0.132±0.018,LRP:0.092.±0.018,U=0.000,P〈0.01).The expressions of P-gp and LRP in lesions of FCD Ⅱ(3.809 ±0.842 and 0.655±0.303,respectively)were higher than that in surrounding regions(2.636 ±0.622 and 0.290±0.096,U value were 6.000 and 4.500,both P〈0.01).Conclusions P-gp,MRP and LRP expressed at different position of focal cortical dysplasia,suggesting that their roles were distinctive.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第7期473-478,共6页 Chinese Journal of Neurology
基金 北京市科技新星计划资助项目(2006B63) 首都医学发展科研基金资助项目(2007-2070)
关键词 癫痫 皮质发育畸形 P糖蛋白 多药耐药相关蛋白质类 穹窿核糖核蛋白颗粒 Epilepsy Malformations of cortical development P-glycoprotein Multidrug resistance-associated proteins Vault ribonucleoprotein,particles
  • 相关文献

参考文献23

  • 1Sisodiya SM,Lin WR,Harding BN,et al.Drug resistance in epilepsy:expression of drug resistance proteins in common causes of refractory epilepsy.Brain,2002,125:22-31.
  • 2Lazarowski A,Lubieniecki F,Camarero S,et al.Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy.Pediatr Neurol,2004,30:102-106.
  • 3Sisodiya SM,Martinian L,Scheffer GL,et al.Major vault protein,a marker of drug resistance,is upregulated in refractory epilepsy.Epilepsia,2003,44:1388-1396.
  • 4Palmini A,Najm Ⅰ,Avanzini G,et al.Terminology and classification of the cortical dysplasias.Neurology,2004,62:S2-S8.
  • 5卢德宏,陈莉,朴月善.重视难治性癫痫的神经病理学研究[J].中华病理学杂志,2007,36(3):147-149. 被引量:35
  • 6朴月善,陈莉,付永娟,王玮,李勇杰,卢德宏.癫痫相关局灶性皮质发育不良的临床病理学研究[J].中华病理学杂志,2007,36(3):150-154. 被引量:40
  • 7刘静,朴月善,卢德宏,王玮,陈莉,隗立峰,杨虹.难治性癫痫273例的临床病理学分析[J].中华神经科杂志,2009,42(10):676-681. 被引量:8
  • 8Aronica E,Gorter JA,Vliet EA,et al.Overexpression of the human major vault protein in gangliogliomas.Epilepsia,2003,44:1166-1175.
  • 9Rigau V,Morin M,Rousset MC,et al.Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.Brain,2007,130:1942-1956.
  • 10Lazamwski A,Cahana L,Merelli A,et al.Neuronal mdr-1 gene expression after experimental focal hypoxia:a new obstach for neuroprotection?J Neurol Sci,2007,258:84-92.

二级参考文献61

  • 1蔡立新,李勇杰.癫痫外科中双重病理的临床特点与手术治疗[J].立体定向和功能性神经外科杂志,2004,17(3):187-189. 被引量:14
  • 2遇涛,李勇杰,王玉平,张国君,卢德宏,陈莉,蔡立新,杜薇.皮质发育不良导致的难治性部分性癫癎临床特征分析[J].中华神经科杂志,2006,39(3):148-151. 被引量:19
  • 3卢德宏,陈莉,朴月善.重视难治性癫痫的神经病理学研究[J].中华病理学杂志,2007,36(3):147-149. 被引量:35
  • 4朴月善,陈莉,付永娟,王玮,李勇杰,卢德宏.癫痫相关局灶性皮质发育不良的临床病理学研究[J].中华病理学杂志,2007,36(3):150-154. 被引量:40
  • 5Aronica E, Gorter JA, Ramkema M, et al. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia, 2004, 45(5) :441-451.
  • 6Sander JW. Some aspects of prognosis in the epilepsies : a review. Epilepsia, 1993, 34(6) : 1007-1016.
  • 7Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res, 1999, 34 ( 2-3 ) : 109- 122.
  • 8Kwan P, Brodie MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia, 2005,46 ( 2 ) :224-235.
  • 9Sisodiya SM, Martinian L, Scheffer GL, et al. Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia, 2003,44( 11 ) : 1388-1396.
  • 10Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology, 2004, 62 (6 Suppl 3) : S2-S8.

共引文献61

同被引文献35

  • 1马爱梅,赵永波,陈英辉,王乔树,王晓梅,刘文文.多药耐药蛋白对大鼠皮层细胞外液卡马西平和苯妥英钠影响的研究[J].中风与神经疾病杂志,2004,21(6):489-492. 被引量:6
  • 2肖争,王学峰,晏勇,栾国明,阎丽.难治性癫癇患者脑组织中5种耐药基因产物的同步表达及临床意义[J].中华神经科杂志,2004,37(6):500-503. 被引量:17
  • 3朴月善,陈莉,付永娟,王玮,李勇杰,卢德宏.癫痫相关局灶性皮质发育不良的临床病理学研究[J].中华病理学杂志,2007,36(3):150-154. 被引量:40
  • 4Racine RJ. Modification of seizure activity by electrical stimulation : Cortical areas [ J ]. Electroencephalogr Clin Neurophysiol, 1975,38 ( 1 ) : 1 - 12.
  • 5Liu B ,Wang T,Wang L,et al. Up - regulation of major vault protein in the frontal cortex of patients with intractable frontal lobe epilepsy [ J 1. J Neurol Sci,2011,308( 1 -2) :88 -93.
  • 6Aronica E, Gorter JA, van Vliet EA, et al. Overexpression of the human major vault protein in gangliogliomas [ J ]. Epilepsia, 2003,44 ( 9 ): 1166 - 1175.
  • 7Guo Z,Zhu J, Zhao L, et al. Expression and clinical significance of multidrug resistance proteins in brain tumors [ J ]. J Exp Clin Cancer Res , 2010,29 : 122.
  • 8Sisodiya SM, Martinian L, Scheffert GL, et al. Vascular colocalization of P - glycoprotein, multidrug - resistance associated proteinl, breast eance resistance protein and major vault protein in human epileptogenic pathologies. Neuropathology and applied [ J ]. Neurobiology, 2009,32 (1) :51 -63.
  • 9Van Vliet EA, Aronica E, Redeker S, et al. Expression and cellular distribution of major vault protein : A putative marker for pharmacoresis- tance in a rat model for temporal lobe epilepsy[J]. Epilepsia ,2004,45 (12) :1506 -1516.
  • 10Luna - Tortos C, Fedrowitz M, Loscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance - associated proteins ( MRP1,2 and 5 ) that are overexpressed in pharmacoresistant epilepsy[ J]. Neuropharmacology,2010,58 (7) : 1019 - 1032.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部